Thromboprophylaxis.
Thromboembolic disease causes significant morbidity and mortality. This article evaluates those patients at risk and the thromboprophylactic strategies that may be employed.
Grace
R
R
Department of Haematology, St Thomas' Hospital, London.
Hunt
B J
BJ
D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D001458:Bandages; D003663:Decision Trees; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D017052:Hospital Mortality; D006801:Humans; D015994:Incidence; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000379:methods*
D000925:Anticoagulants; D005343:Fibrinolytic Agents